pxm129

Peter A. McCue, MD

Contact Dr. McCue

132 S. 10th Street
Main Building, Suite 285
Philadelphia, PA 19107

(215) 955-5588

Most Recent Peer-reviewed Publications

  1. Transplant glomerulopathy
  2. Composite analysis of immunological and metabolic markers defines novel subtypes of triple negative breast cancer
  3. Role of genetic testing for inherited prostate cancer risk: Philadelphia prostate cancer consensus conference 2017
  4. Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine
  5. VAPC-1 Targeted64Cu-TP3805 kit preparation and its evaluation
  6. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: The largest single-institution experience to date
  7. Common Variable Immunodeficiency Disease and Rectal Squamous Cell Carcinoma: a Case Report of a Rare Syndromic Tumor Type
  8. Comprehensive Immunohistochemical Study of Programmed Cell Death Ligand 1 (PD-L1): Analysis in 5536 Cases Revealed Consistent Expression in Trophoblastic Tumors
  9. β1 integrin- and JNK-dependent tumor growth upon hypofractionated radiation
  10. Immunologic and metabolic features of pancreatic ductal adenocarcinoma define prognostic subtypes of disease
  11. The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells
  12. VPAC1 targeted64Cu-TP3805 positron emission tomography imaging of prostate cancer: Preliminary evaluation in man
  13. Unique metabolic features of pancreatic cancer stroma: Relevance to the tumor compartment, prognosis, and invasive potential
  14. Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer
  15. Structure-based screen identifies a potent small molecule inhibitor of Stat5a/b with therapeutic potential for prostate cancer and chronic myeloid leukemia
  16. Paracrine effect of NRG1 and HGF drives resistance to MEK inhibitors in metastatic uveal melanoma
  17. The endogenous cell-fate factor dachshund restrains prostate epithelial cell migration via repression of cytokine secretion via a CXCL signaling module
  18. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
  19. Sox10 - A marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: A systematic analysis of 5134 tumors
  20. Selective impact of CDK4/6 suppression on patient-derived models of pancreatic cancer